Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017

November 16, 2017

ANN ARBOR, Mich., Nov. 16, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today announced that the NYSE American has advised that trading of the Company’s common shares under the symbol “ZOM” will commence on November 21, 2017, subject to the effectiveness… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Announces NYSE American Listing Approval

November 10, 2017

ANN ARBOR, Mich., Nov. 10, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or the “Company”), a veterinary pharmaceutical and health care solutions company, today announced that the NYSE American has approved the Company’s common shares for listing. Trading of the common shares on the NYSE American will not commence until after Zomedica’s Registration… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Announces Third Quarter 2017 Financial Results

November 9, 2017

ANN ARBOR, Mich., Nov. 9, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed unaudited interim consolidated financial results for the three and nine months ended September 30, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under International… [ READ MORE ]

Zomedica Pharmaceuticals Corp. to Present at Jefferies 2017 London Healthcare Conference and LD Micro Main Event 2017

November 8, 2017

ANN ARBOR, Mich., Nov. 8, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will present at the Jefferies 2017 London Healthcare Conference on November 15 in London, UK, and at the LD Micro Main Event 2017 on December 5 in Los Angeles, CA.… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Announces US$5M Unsecured Working Capital Loan Facility

October 18, 2017

ANN ARBOR, Mich., Oct. 18, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM) (“Zomedica” or the “Company”), a veterinary pharmaceutical and health care solutions company, today announced that it has entered into a loan arrangement with a shareholder of the Company, pursuant to which such shareholder has agreed to provide a loan facility to… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Amends Quorum Requirement for Shareholder Meetings

September 21, 2017

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM) (“Zomedica” or the “Company”), a veterinary pharmaceutical and health care solutions company, today announced that an amendment to its bylaws has been approved by the directors, whereby the quorum for the transaction of business at any meeting of the shareholders shall… [ READ MORE ]

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

September 21, 2017

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will present at the 2017 Disruptive Growth Company Showcase NYC, presented by SeeThruEquity and RHK Capital, on Wednesday, September 27 at the Grand Hyatt in New York City. Chief Executive… [ READ MORE ]

Zomedica Appoints PCG Advisory Group for Investor Relations and Announces Option Grants

August 14, 2017

ANN ARBOR, Mich., Aug. 14, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM) (“Zomedica”), a veterinary pharmaceutical and health care solutions company, today announced that it has retained PCG Advisory Group, a leading integrated communications firm, to serve as an advisor for investor relations and social media communications strategies. “We are very pleased to… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Announces Second Quarter 2017 Financial Results

August 10, 2017

ANN ARBOR, Mich., Aug. 10, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed unaudited interim consolidated financial results for the three and six months ended June 30, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under International… [ READ MORE ]